Codexis Inc. (NASDAQ: CDXS) Stock Information | RedChip

Codexis Inc. (NASDAQ: CDXS)


$4.9200
-0.3600 ( -6.46% ) 181.1K

Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products, leveraging its proprietary CodeEvolver directed evolution technology platform. The firm's products and services include Biocatalysts and Enzymes. The company generates majority of its revenue through product sales and also licenses its technology platform CodeEvolver to pharmaceutical companies enabling them to use this technology, in-house, to engineer enzymes for their own businesses. Geographically, it derives revenue from the United States, Ireland, Switzerland, China and other markets.

Market Data


Open


$4.9200

Previous close


$5.2800

Volume


181.1K

Market cap


$403.63M

Day range


$4.9100 - $5.3960

52 week range


$2.5300 - $6.0800

SEC Filings


Form Type Description Pages Date
8-k 8K-related 14 Nov 12, 2024
3 Insider transactions 2 Nov 12, 2024
4 Insider transactions 1 Nov 12, 2024
8-k 8K-related 15 Oct 31, 2024
10-q Quarterly Reports 84 Oct 31, 2024
4 Insider transactions 1 Oct 28, 2024
8-k 8K-related 13 Oct 22, 2024
4 Insider transactions 2 Oct 10, 2024
4 Insider transactions 1 Oct 10, 2024
3 Insider transactions 2 Oct 10, 2024

Latest News